Ubisoft closing Trials developer RedLynx and cutting jobs in Singapore studio - GamesIndustry.biz
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Latest round of cuts proposes the loss of 52 roles in Finland and 70 in Singapore
Ubisoft has proposed the closure of Finnish studio RedLynx, creator of the Trial franchise, and major job losses at Ubisoft Singapore, lead developer of the ill-fated Skull and Bones. The cuts are the latest in the firm's ongoing restructuring, as it seeks to dramatically reduce costs and reform into a new Creative Houses structure. Both studios had been placed into the Creative Network in that organization, providing central support to other teams.
This article is an excerpt. To read the full content, visit the original source. GamesIndustry.biz
Related articles
Ubisoft shuts down beloved 26-year-old studio, lays off Black Flag remake devs - Polygon.com
Elijah is a freelance news writer at Polygon. He was an associate editor at The A. V. Club and Paste, and has been featured in outlets like Game Informer, Fanbyte, Unwinnable, and more. He loves media in all forms, from fighting games and horror flicks to slow cinema and visual novels. He's from the Greater Boston area. The game industry isn't doing well. Ubisoft is doing worse.
Ubisoft and the technology trap - by Joost van Dreunen - SuperJoost Playlist
Massive Entertainment Now Leads Splinter Cell, Ghost Recon, and The Division at Ubisoft - Insider Gaming
It has been announced that Massive Entertainment will now be Ubisoft’s Creative House 2, taking the lead on Tom Clancy’s The Division, Ghost Recon, and Splinter Cell, alongside new original IP, including March of Giants. The announcement follows Ubisoft’s ongoing restructuring, which will see the French publisher cut an additional 180 million euros in its “third and final phase” of restructuring. Previously, Ubisoft said this would be 200 million euros; however, Insider Gaming understands that this has been cut to 180 million euros.
0 comments
No comments yet. Be the first to share your thoughts!